AfsheenIqbalMD

PubMed

• 6 citations
  Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced-Mutant Non-Small Cell Lung Cancer.
  Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg, Bob T Li, Afsheen Iqbal, Isabel Preeshagul, Fernando C Santini, Juliana Eng, Marc Ladanyi, Soo-Ryum Yang, Rongl...> ;JCO Precision Oncology. 2023 Jun 1
• Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.
  Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G...> ;Clinical Cancer Research. 2023 Apr 14
• 2 citations
  A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma.
  Andreas Rimner, Prasad S Adusumilli, Michael D Offin, Stephen B Solomon, Etay Ziv, Sara A Hayes, Michelle S Ginsberg, Jennifer L Sauter, Daphna Y Gelblum, Annemarie F ...> ;JTO Clinical and Research Reports. 2023 Jan 1
• 39 citations
  Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
  Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust, Paul K Paik, Jamie E Chaft, Gowtham Jayakumaran, A Rose Brannon, Ryma Benayed, Ahmet Zehir, Mar...> ;Nature Medicine. 2022 Nov 1
• 12 citations
  Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib.
  Noura J. Choudhury, Alex Makhnin, Yosef Tobi, Robert M Daly, Isabel R Preeshagul, Afsheen Iqbal, Linda S Ahn, Sara A. Hayes, Glenn Heller, Mark G. Kris, Gregory J Riel...> ;JCO Precision Oncology. 2021 Apr 22
• 9 citations
  Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor
  Jia Luo, Alex Makhnin, Yosef Tobi, Linda Ahn, Sara A. Hayes, A. Iqbal, Kenneth K.-S. Ng, Maria E. Arcila, Gregory J Riely, Mark G. Kris, Helena A. Yu> ;JCO Precision Oncology. 2021 Jan 11
• 153 citations
  COVID-19 in patients with lung cancer
  Jia Luo, Hira Rizvi, Isabel Ruth Preeshagul, Jacklynn V. Egger, David Hoyos, Chaitanya Bandlamudi, Caroline G. McCarthy, Christina Falcon, Adam J. Schoenfeld, Kathryn ...> ;Annals of Oncology. 2020 Oct 1
• 8 citations
  A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
  Paul K. Paik, Rachel Kim, Linda Ahn, Andrew J. Plodkowski, Ai Ni, Mark T.A. Donoghue, Philip Jonsson, Miguel A. Villalona-Calero, Kenneth K. Ng, Daniel C. McFarland, J...> ;Clinical Cancer Research. 2020 Apr 15
• 199 citations
  Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
  Adam J. Schoenfeld, Kathryn C. Arbour, Hira Rizvi, A. Iqbal, Shirish M. Gadgeel, Jeffrey Girshman, Mark G. Kris, G. J. Riely, Helena A. Yu, Matthew D. Hellmann> ;Annals of Oncology. 2019 May 1
• Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.
  Christopher D. Jakubowski, Andrew J. Plodkowski, Jason C. Chang, Natasha Rekhtman, A. Iqbal, Paul K. Paik, Helena A. Yu> ;Clinical Lung Cancer. 2017 Jan 1
• 94 citations
  Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes
  Jarushka Naidoo, Maria Laureana Santos-Zabala, Tunc Iyriboz, Kaitlin M. Woo, Camelia S. Sima, John J. Fiore, Mark G. Kris, Gregory J. Riely, Piro Lito, Afsheen Iqbal, ...> ;Clinical Lung Cancer. 2016 Sep 1
• 1 citations
  A Case of Malignant Metastatic Pheochromocytoma After Eight Years of Primary Diagnosis.
  Sakshi Kapur, A. Iqbal, Miles B. Levin> ;World Journal of Oncology. 2014 Nov 21
• Join now to see all